Neostigmine Methylsulfate (REMEDYREPACK INC.)


Welcome to the PulseAid listing for the Neostigmine Methylsulfate drug offered from REMEDYREPACK INC.. This Cholinesterase Inhibitor [EPC],Cholinesterase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: REMEDYREPACK INC.
NON-PROPRIETARY NAME: Neostigmine Methylsulfate
SUBSTANCE NAME: NEOSTIGMINE METHYLSULFATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Cholinesterase Inhibitor [EPC],Cholinesterase Inhibitors [MoA]
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION, SOLUTION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2015-10-19
END MARKETING DATE: 0000-00-00


Neostigmine Methylsulfate HUMAN PRESCRIPTION DRUG Details:

Item DescriptionNeostigmine Methylsulfate from REMEDYREPACK INC.
LABELER NAME: REMEDYREPACK INC.
DEA SCHEDULE:
ACTIVE STRENGTH: 1(mg/mL)
START MARKETING DATE: 2015-10-19
END MARKETING DATE: 0000-00-00
PRODUCT ID: 61786-452_4c4856b1-862c-452e-e054-00144ff88e88
PRODUCT NDC: 61786-452
APPLICATION NUMBER: NDA203629

Other NEOSTIGMINE METHYLSULFATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Amphastar Pharmaceuticals, Inc.NEOSTIGMINE METHYLSULFATE
Avadel Legacy Pharmaceuticals, LLCBloxiverz
Cantrell Drug CompanyNeostigmine Methylsulfate
Fresenius Kabi USA, LLCNeostigmine Methylsulfate
General Injectables and Vaccines, IncNeostigmine Methylsulfate
Par Pharmaceutical, Inc.NEOSTIGMINE METHYLSULFATE
REMEDYREPACK INC.Neostigmine Methylsulfate
West-Ward Pharmaceuticals Corp.Neostigmine Methylsulfate